Molecular Simulations of PEGylated Biomolecules, Liposomes, and Nanoparticles for Drug Delivery Applications
Since the first polyethylene glycol (PEG)ylated protein was approved by the FDA in 1990, PEGylation has been successfully applied to develop drug delivery systems through experiments, but these experimental results are not always easy to interpret at the atomic level because of the limited resolutio...
Saved in:
Main Author: | Hwankyu Lee (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanoparticle-based biomolecules in cancer diagnosis, therapy, drug delivery and prognosis
by: Sowmya SV, et al.
Published: (2024) -
Molecular Modeling of Protein Corona Formation and Its Interactions with Nanoparticles and Cell Membranes for Nanomedicine Applications
by: Hwankyu Lee
Published: (2021) -
Pegylated liposomal doxorubicin in ovarian cancer
by: Robert Strother, et al.
Published: (2009) -
New Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics
Published: (2022) -
New Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics
by: Helena P. Felgueiras
Published: (2022)